Influence of different anticoagulants on monocyte procoagulant functions and monocyte-platelet aggregates formation

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 8, 2012, Pages 1698-1702

  Basavaraj, M G ^a   Osterud B ^a   Hansen, J B ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; PROCOAGULANT;

ARTICLE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; MONOCYTE PLATELET AGGREGATE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOGENICITY;

ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD PLATELETS; CITRIC ACID; EDETIC ACID; FEMALE; HEPARIN; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MALE; MIDDLE AGED; MONOCYTES; PLATELET ADHESIVENESS; RNA, MESSENGER; SPECIMEN HANDLING; THROMBOPLASTIN; TIME FACTORS;

EID: 84865244162     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04821.x     Document Type: Article

References (14)

1. Moniuszko M, Kowal K, Rusak M, Pietruczuk M, Dabrowska M, Bodzenta-Lukaszyk A. Monocyte CD163 and CD36 expression in human whole blood and isolated mononuclear cell samples: influence of different anticoagulants. Clin Vaccine Immunol 2006; 13: 704-7.
2. Bournazos S, Rennie J, Hart SP, Dransfield I. Choice of anticoagulant critically affects measurement of circulating platelet-leukocyte complexes. Arterioscler Thromb Vasc Biol 2008; 28: e2-3.
3. Basavaraj MG, Gruber FX, Sovershaev M, Appelbom HI, Osterud B, Petersen LC, Hansen JB. The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes. Thromb Res 2010; 126: 418-25.
4. Bach RR. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem 1988; 23: 339-68.
5. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9: 458-62.
6. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 1988; 71: 335-43.
7. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357: 2482-94.
8. Michelson AD, Barnard MR, Krueger LA, Frelinger AL III, Furman MI. Evaluation of platelet function by flow cytometry. Methods 2000; 21: 259-70.
9. Freedman JE, Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 2002; 105: 2130-2.
10. Shantsila E, Lip GY. The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. Thromb Haemost 2009; 102: 916-24.
11. Basavaraj MG, Braekkan SK, Brodin E, Osterud B, Hansen JB. Monocyte count and procoagulant functions are associated with risk of venous thromboembolism: the Tromso study. J Thromb Haemost 2011; 9: 1673-6.
12. Engstad CS, Gutteberg TJ, Osterud B. Modulation of blood cell activation by four commonly used anticoagulants. Thromb Haemost 1997; 77: 690-6.
13. Ibeagha-Awemu EM, Ibeagha AE, Zhao X. The influence of different anticoagulants and sample preparation methods on measurement of mCD14 on bovine monocytes and polymorphonuclear neutrophil leukocytes. BMC Res Notes 2012; 5: 93.
14. Gao C, Boylan B, Fang J, Wilcox DA, Newman DK, Newman PJ. Heparin promotes platelet responsiveness by potentiating alphaIIbbeta3-mediated outside-in signaling. Blood 2011; 117: 4946-52.